Disseminated histoplasmosis in a paediatric patient at a referral hospital in Nairobi, Kenya
Anne-Marie Macharia, Edwin Oloo Walong
The Pan African Medical Journal. ;34:139. doi:10.11604/pamj..34.139.20685

Create an account  |  Sign in
"Better health through knowledge sharing and information dissemination "

Images in clinical medicine

Disseminated histoplasmosis in a paediatric patient at a referral hospital in Nairobi, Kenya

Anne-Marie Macharia, Edwin Oloo Walong
Pan Afr Med J. 2019; 34:139. doi:10.11604/pamj.2019.34.139.20685. Published 08 Nov 2019

A two year old boy presented with two-month history of fever and abdominal swelling. He developed jaundice and had experienced significant weight loss. There was no history of tuberculosis contact. At presentation the patient was febrile with tachypnoea and tachycardia. He had pallor, jaundice, generalized lymphadenopathy, petechiae, gingival bleeding and epistaxis. The liver was palpable 8 cm below the costal margin with splenomegally 9 cm below the costal margin. Laboratory investigations were notable for severe anaemia with leucopenia and severe thrombocytopenia. CRP was elevated at 55mg/l. He was HIV negative. Liver and renal function were normal. The chest radiograph was unremarkable. Abdominal ultrasound showed enlarged homogenous liver, span 9.2 cm, with no focal masses. The spleen was enlarged with a span of 10.8 cm. There was no adenopathy or ascites.A bone marrow aspirate was done, results below. What is your diagnosis? Treatment was started with amphotericin B deoxycholate, but he succumbed after 5 days of treatment. Bone marrow aspirate revealed macrophages with severe infestation by fungal spores of histoplasma. Histoplamosis is a dimorphic fungus endemic in parts of Africa. Severe and disseminated infection occurs in immunosuppression and at extremes of age. Our patient presented with lymphadenopathy and hepatosplenomegally, suggesting disseminated histoplamosis. Severe cases are treated with amphotericin B which rapidly eradicates fungaemia, then transitioned to itraconazole to complete at least one year of treatment.

Corresponding author:
Anne-Marie Macharia, Unit of Clinical Infectious Disease, Department of Clinical Medicine and Therapeutics, University of Nairobi, Nairobi, Kenya

©Anne-Marie Macharia et al. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

More images in clinical medicine


PAMJ Images in Medicine and Public Health are archived on Pubmed Central. Access PAMJ archives on PMC here

Volume 34 (September - December 2019)

This image

Share this image:

Filter images [Reset filter]

By language

PAMJ is published in collaboration with the African Field Epidemiology Network (AFENET)
Currently tracked by: DOAJ, AIM, Google Scholar, AJOL, EBSCO, Scopus, Embase, IC, HINARI, Global Health, PubMed Central, PubMed/Medline, Ulrichsweb, More to come . Member of COPE.

ISSN: 1937-8688. © 2019 - Pan African Medical Journal. All rights reserved